Evermay Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.3K | Hold |
250
| – | – | ﹤0.01% | 397 |
|
|
2025
Q1 | $17.6K | Hold |
250
| – | – | ﹤0.01% | 399 |
|
|
2024
Q4 | $21.5K | Hold |
250
| – | – | ﹤0.01% | 378 |
|
|
2024
Q3 | $29.8K | Hold |
250
| – | – | ﹤0.01% | 372 |
|
|
2024
Q2 | $35.7K | Hold |
250
| – | – | 0.01% | 368 |
|
|
2024
Q1 | $32.3K | Hold |
250
| – | – | ﹤0.01% | 386 |
|
|
2023
Q4 | $25.9K | Hold |
250
| – | – | ﹤0.01% | 379 |
|
|
2023
Q3 | $22.7K | Hold |
250
| – | – | ﹤0.01% | 370 |
|
|
2023
Q2 | $20.2K | Hold |
250
| – | – | ﹤0.01% | 378 |
|
|
2023
Q1 | $20K | Hold |
250
| – | – | ﹤0.01% | 367 |
|
|
2022
Q4 | $16.9K | Hold |
250
| – | – | ﹤0.01% | 377 |
|
|
2022
Q3 | $12K | Hold |
250
| – | – | ﹤0.01% | 382 |
|
|
2022
Q2 | $14K | Hold |
250
| – | – | ﹤0.01% | 367 |
|
|
2022
Q1 | $14K | Hold |
250
| – | – | ﹤0.01% | 387 |
|
|
2021
Q4 | $14K | Hold |
250
| – | – | ﹤0.01% | 381 |
|
|
2021
Q3 | $12K | Sell |
250
-6,220
| -96% | -$299K | ﹤0.01% | 372 |
|
|
2021
Q2 | $271K | Hold |
6,470
| – | – | 0.05% | 152 |
|
|
2021
Q1 | $218K | Hold |
6,470
| – | – | 0.04% | 164 |
|
|
2020
Q4 | $226K | Hold |
6,470
| – | – | 0.05% | 160 |
|
|
2020
Q3 | $225K | Hold |
6,470
| – | – | 0.06% | 147 |
|
|
2020
Q2 | $212K | Buy |
+6,470
| New | +$212K | 0.06% | 147 |
|